The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression - PubMed (original) (raw)
The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression
Jill M Mooney et al. J Immunol. 2004.
Abstract
2B4 (CD244) is a receptor belonging to the CD2-signaling lymphocytic activation molecule family and is found on all murine NK cells and a subset of NKT and CD8+ T cells. Murine 2B4 is expressed as two isoforms (2B4 short and 2B4 long) that arise by alternative splicing. They differ only in their cytoplasmic domains and exhibit opposing function when expressed in the RNK-16 cell line. The ligand for 2B4, CD48, is expressed on all hemopoietic cells. Previous studies have shown that treatment of NK cells with a 2B4 mAb results in increased cytotoxicity and IFN-gamma production. In this report, we used CD48+/- variants of the P815 tumor cell line and 2B4 knockout mice to show that engagement of 2B4 by its counterreceptor, CD48, expressed on target cells leads to an inhibition in NK cytotoxicity. The addition of 2B4 or CD48 mAb relieves this inhibition resulting in enhanced target cell lysis. This 2B4-mediated inhibition acts independently of signaling lymphocytic activation molecule-associated protein expression. Imaging studies show that 2B4 preferentially accumulates at the interface between NK and target cells during nonlytic events also indicative of an inhibitory receptor. This predominant inhibitory function of murine 2B4 correlates with increased 2B4 long isoform level expression over 2B4 short.
Copyright 2004 The American Association of Immunologists, Inc.
Similar articles
- Cutting edge: the NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells.
Lee KM, Bhawan S, Majima T, Wei H, Nishimura MI, Yagita H, Kumar V. Lee KM, et al. J Immunol. 2003 May 15;170(10):4881-5. doi: 10.4049/jimmunol.170.10.4881. J Immunol. 2003. PMID: 12734329 - Mutational analysis of the human 2B4 (CD244)/CD48 interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells.
Mathew SO, Kumaresan PR, Lee JK, Huynh VT, Mathew PA. Mathew SO, et al. J Immunol. 2005 Jul 15;175(2):1005-13. doi: 10.4049/jimmunol.175.2.1005. J Immunol. 2005. PMID: 16002700 - Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
Tangye SG, Phillips JH, Lanier LL, Nichols KE. Tangye SG, et al. J Immunol. 2000 Sep 15;165(6):2932-6. doi: 10.4049/jimmunol.165.6.2932. J Immunol. 2000. PMID: 10975798 - Of mice and men: different functions of the murine and human 2B4 (CD244) receptor on NK cells.
Vaidya SV, Mathew PA. Vaidya SV, et al. Immunol Lett. 2006 Jun 15;105(2):180-4. doi: 10.1016/j.imlet.2006.02.006. Epub 2006 Mar 15. Immunol Lett. 2006. PMID: 16621032 Review. - 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.
Nakajima H, Colonna M. Nakajima H, et al. Hum Immunol. 2000 Jan;61(1):39-43. doi: 10.1016/s0198-8859(99)00170-6. Hum Immunol. 2000. PMID: 10658976 Review.
Cited by
- The Macrophage Landscape Across the Lifespan of a Human Cardiac Allograft.
Li X, Turaga D, Li RG, Tsai CR, Quinn JN, Zhao Y, Wilson R, Carlson K, Wang J, Spinner JA, Hickey EJ, Adachi I, Martin JF. Li X, et al. Circulation. 2024 May 21;149(21):1650-1666. doi: 10.1161/CIRCULATIONAHA.123.065294. Epub 2024 Feb 12. Circulation. 2024. PMID: 38344825 - SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy.
Farhangnia P, Ghomi SM, Mollazadehghomi S, Nickho H, Akbarpour M, Delbandi AA. Farhangnia P, et al. Front Immunol. 2023 May 11;14:1174138. doi: 10.3389/fimmu.2023.1174138. eCollection 2023. Front Immunol. 2023. PMID: 37251372 Free PMC article. Review. - CD244 represents a new therapeutic target in head and neck squamous cell carcinoma.
Agresta L, Lehn M, Lampe K, Cantrell R, Hennies C, Szabo S, Wise-Draper T, Conforti L, Hoebe K, Janssen EM. Agresta L, et al. J Immunother Cancer. 2020 Mar;8(1):e000245. doi: 10.1136/jitc-2019-000245. J Immunother Cancer. 2020. PMID: 32217758 Free PMC article. - Recalling the Biological Significance of Immune Checkpoints on NK Cells: A Chance to Overcome LAG3, PD1, and CTLA4 Inhibitory Pathways by Adoptive NK Cell Transfer?
Lanuza PM, Pesini C, Arias MA, Calvo C, Ramirez-Labrada A, Pardo J. Lanuza PM, et al. Front Immunol. 2020 Jan 9;10:3010. doi: 10.3389/fimmu.2019.03010. eCollection 2019. Front Immunol. 2020. PMID: 31998304 Free PMC article. Review. - The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment.
Agresta L, Hoebe KHN, Janssen EM. Agresta L, et al. Front Immunol. 2018 Nov 28;9:2809. doi: 10.3389/fimmu.2018.02809. eCollection 2018. Front Immunol. 2018. PMID: 30546369 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous